Nefazodone- and/or sodium tetradecyl sulfate-associated leukopenia, fever, and shaking chills in a patient with premenstrual dysphoric disorder.
Fogelson
D L
DL
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D008875:Middle Aged; D010879:Piperazines; D011293:Premenstrual Syndrome / Q000188:drug therapy*; D012597:Sclerosing Solutions / Q000009:adverse effects*; D012768:Shivering; D012981:Sodium Tetradecyl Sulfate / Q000009:adverse effects*; D014230:Triazoles / Q000009:adverse effects*; D014648:Varicose Veins / Q000188:drug therapy
D018687:Antidepressive Agents, Second-Generation; D010879:Piperazines; D012597:Sclerosing Solutions; D014230:Triazoles; C051752:nefazodone; D012981:Sodium Tetradecyl Sulfate